141 related articles for article (PubMed ID: 907841)
21. Extreme thrombocytosis and cardiovascular surgery: risks and management.
Natelson EA
Tex Heart Inst J; 2012; 39(6):792-8. PubMed ID: 23304015
[TBL] [Abstract][Full Text] [Related]
22. [Effect of Highvolume Platelet Reduction Therapy on White Blood Cell Count and Hemoglobin Level in Patients with Thrombocytosis].
Wu YJ; Wu Y; Li HS; Chen BC; Liu Y; Wu YQ; Liang SY; Liang MQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1607-1611. PubMed ID: 31607320
[TBL] [Abstract][Full Text] [Related]
23. Primary thrombocythemia: a current perspective.
Mughal TI
Stem Cells; 1995 Jul; 13(4):355-9. PubMed ID: 7549894
[TBL] [Abstract][Full Text] [Related]
24. 5-year incidence of thrombocytosis and the effect on heparin dose response and heparin requirements.
Gayoso JM
J Extra Corpor Technol; 1999 Dec; 31(4):184-90. PubMed ID: 10915475
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic cytapheresis using the Fenwal CS-3000 blood cell separator.
Steeper TA; Smith JA; McCullough J
Vox Sang; 1985; 48(4):193-200. PubMed ID: 3984305
[TBL] [Abstract][Full Text] [Related]
26. Bleeding and thrombosis in the myeloproliferative disorders.
Schafer AI
Blood; 1984 Jul; 64(1):1-12. PubMed ID: 6375757
[TBL] [Abstract][Full Text] [Related]
27. [Primary thrombocytosis and plateletpheresis--2 cases].
Maeda H; Sueyoshi A; Iwanaga T; Horiuchi A
Rinsho Ketsueki; 1982 Oct; 23(10):1651-5. PubMed ID: 7154264
[No Abstract] [Full Text] [Related]
28. Rapid reduction of platelet count in essential hemorrhagic thrombocythemia by discontinuous flow plateletpheresis.
Younger J; Umlas J
Am J Med; 1978 Apr; 64(4):659-61. PubMed ID: 565590
[TBL] [Abstract][Full Text] [Related]
29. Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2a.
Tichelli A; Gratwohl A; Berger C; Lori A; Würsch A; Dieterle A; Thomssen C; Nissen C; Holdener E; Speck B
Blut; 1989 Jan; 58(1):15-9. PubMed ID: 2644994
[TBL] [Abstract][Full Text] [Related]
30. Reversible acute sensorineural hearing loss associated with essential thrombocytosis.
Grisell DL; Mills GM
Arch Intern Med; 1986 Sep; 146(9):1813. PubMed ID: 3753122
[TBL] [Abstract][Full Text] [Related]
31. Successful microsurgical tissue transfer in a patient with postsplenectomy thrombocytosis treated with platelet-phoresis.
Hsiao HT; Ou SY
J Reconstr Microsurg; 1997 Nov; 13(8):555-8. PubMed ID: 9401983
[TBL] [Abstract][Full Text] [Related]
32. alpha Interferon treatment of essential thrombocythaemia and other myeloproliferative disorders with excessive thrombocytosis.
Yataganas X; Meletis J; Plata E; Viniou N; Deligiannis F; Tsekoura C; Voscaridou E; Boussiotis V; Rombos J; Vayopoulos G
Eur J Cancer; 1991; 27 Suppl 4():S69-71. PubMed ID: 1799484
[TBL] [Abstract][Full Text] [Related]
33. Platelet apheresis for digital gangrene due to thrombocytosis in chronic myeloid leukaemia.
Win N; Mitchell DC
Clin Lab Haematol; 2001 Feb; 23(1):65-6. PubMed ID: 11422234
[TBL] [Abstract][Full Text] [Related]
34. Hematologic Conditions: Platelet Disorders.
Mumford J; Flanagan B; Keber B; Lam L
FP Essent; 2019 Oct; 485():32-43. PubMed ID: 31613566
[TBL] [Abstract][Full Text] [Related]
35. [Mechanical plasmapheresis by means of the Haemonetics-ultralite- plasma collection system: 2. Generation of platelet-rich plasma].
Richter E; Pawlow I; Matthes G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):127-33. PubMed ID: 1695166
[TBL] [Abstract][Full Text] [Related]
36. Plateletpheresis using the haemonetics model 30 cell separator.
Nusbacher J; Scher ML; MacPherson JL
Vox Sang; 1977 Jul; 33(1):9-15. PubMed ID: 883246
[TBL] [Abstract][Full Text] [Related]
37. Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile.
Steurer M; Gastl G; Jedrzejczak WW; Pytlik R; Lin W; Schlögl E; Gisslinger H
Cancer; 2004 Nov; 101(10):2239-46. PubMed ID: 15476273
[TBL] [Abstract][Full Text] [Related]
38. [Plateletpheresis in primary thrombocythemia].
Suzuki K; Asano Y; Yokoyama S; Tomoyasu S; Nunogami N
Rinsho Ketsueki; 1982 Oct; 23(10):1661-7. PubMed ID: 7154265
[No Abstract] [Full Text] [Related]
39. Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosis.
Talpaz M; Kurzrock R; Kantarjian H; O'Brien S; Gutterman JU
Am J Med; 1989 May; 86(5):554-8. PubMed ID: 2712063
[TBL] [Abstract][Full Text] [Related]
40. [Therapy of thrombocytosis in myeloproliferative syndromes using recombinant interferon-alpha-2a].
Tichelli A; Gratwohl A; Delacrétaz F; Dazzi H; Stebler C; Wernli M; Holdener EE; Nissen C; Speck B
Schweiz Med Wochenschr; 1989 Sep; 119(39):1347-52. PubMed ID: 2799342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
